Another literature reported that in ischemic heart disease, the combination of lncCIRBIL and BCL2-related transcription factor1 (Bclaf1) had a protective effect on I/R damage and was a potential target for treating ischemic heart disease (37). Here, BCLAF1 is linked to coronary artery disorder.